Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

W Schultze-Seemann

Showing results (1-10 of 35) with videos related to

Pageof 4
Sort By:
Fortschritte Der Medizin|September 10, 1993
[Benign prostatic hyperplasia--choice of therapy in the elderly]W Schultze-Seemann
Fortschritte Der Medizin|July 20, 1993
[Limits of surgical therapy of prostate cancer in the aged?]W Schultze-Seemann
BJU International|May 8, 1999
Kidney-preserving tumour resection in renal cell carcinoma with photodynamic detection by 5-aminolaevulinic acid: preclinical and preliminary clinical resultsG Popken, U Wetterauer, W Schultze-Seemann
Urological Research|July 28, 1999
Microsurgical epididymovasostomy in the rat: comparison of end-to-side and two invagination techniquesG Popken, U Wetterauer, W Schultze-Seemann
Urology|September 28, 2002
Bilateral pedicled myocutaneous vertical rectus abdominus muscle flaps to close vesicovaginal and pouch-vaginal fistulas with simultaneous vaginal and perineal reconstruction in irradiated pelvic woundsRaymund E Horch, G Gitsch, W Schultze-Seemann
Urological Research|January 1, 1994
Intravesical idarubicin--a phase-I studyW Schultze-Seemann, K Mross, K Burk, et al.
International Journal of Andrology|September 28, 1998
Transurethral resection of cystic and non-cystic ejaculatory duct obstructionsG Popken, U Wetterauer, W Schultze-Seemann, et al.
European Urology|June 5, 1998
Anastomotic stricture after radical prostatectomy. Incidence, findings and treatmentG Popken, H Sommerkamp, W Schultze-Seemann, et al.
British Journal of Cancer|August 17, 2000
Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancerU Elsässer-Beile, M Rindsfüser, T Grussenmeyer, et al.
European Journal of Clinical Pharmacology|August 22, 2000
Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IXG Popken, W Schultze-Seemann, K U Seiler, et al.
Pageof 4

Showing results (1-10 of 35) with videos related to

Sort By:
Pageof 4
Fortschritte Der Medizin|September 10, 1993
[Benign prostatic hyperplasia--choice of therapy in the elderly]W Schultze-Seemann
Fortschritte Der Medizin|July 20, 1993
[Limits of surgical therapy of prostate cancer in the aged?]W Schultze-Seemann
BJU International|May 8, 1999
Kidney-preserving tumour resection in renal cell carcinoma with photodynamic detection by 5-aminolaevulinic acid: preclinical and preliminary clinical resultsG Popken, U Wetterauer, W Schultze-Seemann
Urological Research|July 28, 1999
Microsurgical epididymovasostomy in the rat: comparison of end-to-side and two invagination techniquesG Popken, U Wetterauer, W Schultze-Seemann
Urology|September 28, 2002
Bilateral pedicled myocutaneous vertical rectus abdominus muscle flaps to close vesicovaginal and pouch-vaginal fistulas with simultaneous vaginal and perineal reconstruction in irradiated pelvic woundsRaymund E Horch, G Gitsch, W Schultze-Seemann
Urological Research|January 1, 1994
Intravesical idarubicin--a phase-I studyW Schultze-Seemann, K Mross, K Burk, et al.
International Journal of Andrology|September 28, 1998
Transurethral resection of cystic and non-cystic ejaculatory duct obstructionsG Popken, U Wetterauer, W Schultze-Seemann, et al.
European Urology|June 5, 1998
Anastomotic stricture after radical prostatectomy. Incidence, findings and treatmentG Popken, H Sommerkamp, W Schultze-Seemann, et al.
British Journal of Cancer|August 17, 2000
Enhanced expression of IFN-gamma mRNA in CD4(+)or CD8(+)tumour-infiltrating lymphocytes compared to peripheral lymphocytes in patients with renal cell cancerU Elsässer-Beile, M Rindsfüser, T Grussenmeyer, et al.
European Journal of Clinical Pharmacology|August 22, 2000
Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IXG Popken, W Schultze-Seemann, K U Seiler, et al.
Pageof 4